Amorolfine clinical trials
How each study uses amorolfine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the amorolfine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 2
Mahidol University (1) · Oystershell NV (1) · National Taiwan University Hospital (1)
Studies
Open first, then newest update. How each study uses amorolfine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- CLINICAL INVESTIGATION FOR THE EVALUATION OF EFFICACY AND SAFETY OF TWO PRODUCTS FOR THE TREATMENT OF ONYCHOMYCOSISRecruitingNot applicableOystershell NVNCT06689852Written as Loceryl 5%
- Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte OnychomycosisCompletedPhase 4Mahidol UniversityNCT02812043Written as Amorolfine
- A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail OnychomycosisStatus unknownNot applicableNational Taiwan University HospitalNCT01929187Written as Loceryl
As the comparator · 8 — what is tested is compared with amorolfine
- Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis TreatmentNot yet recruitingNot applicableOystershell NVNCT06254027Written as Loceryl
- Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis TreatmentCompletedNot applicableChulalongkorn UniversityNCT03098342Written as Amorolfine 5% Nail Lacquer
- Efficacy and Safety of a Medical Device for the Treatment of Toenail OnychomycosisCompletedNot applicableOystershell NVNCT03382717Written as Loceryl 5%
- Clinical Evaluation of Efficacy and Safety of a Medical Device for the Treatment of Toenail OnychomycosisCompletedNot applicableOystershell NVNCT04961684Written as Loceryl 5%
- Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail OnychomycosisCompletedPhase 3Polichem S.A.NCT02549001Written as amorolfine 5%
- Clinical Evaluation of the Efficacy of a Medical Device in Treatment of Toenail OnychomycosisCompletedNot applicableOystershell NVNCT03289871Written as Loceryl 5%
- Resin vs. Amorolfine vs. Terbinafine Treatment in OnychomycosisCompletedPhase 4Helsinki University Central HospitalNCT01851590Written as Amorolfine
- Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic OnychomycosisStatus unknownPhase 4Pierre Fabre Dermo CosmetiqueNCT01014637Written as Amorolfine (Antifungal)
Codes
What other systems call amorolfine · ClinicalTrials.gg INT003110
- MeSH (NLM) C038974amorolfineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) AB0BHP2FH0AMOROLFINEConfirmed FDA, NLM, Wikidata
- RxNorm 17804Confirmed FDA, Wikidata
- Wikidata Q123195amorolfineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81332AmorolfineOne source FDA
- DrugBank DB09056One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C038974 | amorolfine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | AB0BHP2FH0 | AMOROLFINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 17804 | — | Confirmed FDA, Wikidata |
| Wikidata | Q123195 | amorolfine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81332 | Amorolfine | One source FDA |
| DrugBank | DB09056 | — | One source Wikidata |
Also registered as amorolfine hydrochloride (UNII 741YH7379H · RxNorm 293865).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.